How can the gut microbiome be targeted to fight multidrug-resistant organisms?

Davido B, Merrick B, Kuijper E, Benech N, Biehl LM, Corcione S, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI)

Open source

DOI
10.1016/j.lanmic.2024.101063
Published
2025 Aug
Container
The Lancet. Microbe
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanmic.2024.101063,
  title = {How can the gut microbiome be targeted to fight multidrug-resistant organisms?},
  author = {Davido B and Merrick B and Kuijper E and Benech N and Biehl LM and Corcione S and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI)},
  year = {2025},
  journal = {The Lancet. Microbe},
  doi = {10.1016/j.lanmic.2024.101063},
  url = {https://doi.org/10.1016/j.lanmic.2024.101063}
}

RIS

TY  - JOUR
TI  - How can the gut microbiome be targeted to fight multidrug-resistant organisms?
AU  - Davido B
AU  - Merrick B
AU  - Kuijper E
AU  - Benech N
AU  - Biehl LM
AU  - Corcione S
AU  - European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI)
PY  - 2025
JO  - The Lancet. Microbe
DO  - 10.1016/j.lanmic.2024.101063
UR  - https://doi.org/10.1016/j.lanmic.2024.101063
ER  - 

APA

B, D., B, M., E, K., N, B., LM, B., S, C., & (ESGHAMI), E. S. O. C. M. A. I. D. (. S. G. F. H. A. M. I. (2025). How can the gut microbiome be targeted to fight multidrug-resistant organisms?. The Lancet. Microbe. https://doi.org/10.1016/j.lanmic.2024.101063

Source records